Mesenchymal stem cells improve renal injury in diabetic rats by inhibiting CD103 + DCs maturation to decline CD8 + T cell responses

MLA

Jingqiu Cheng, et al. “Mesenchymal Stem Cells Improve Renal Injury in Diabetic Rats by Inhibiting CD103 + DCs Maturation to Decline CD8 + T Cell Responses.” The FASEB Journal, vol. 33, Apr. 2019. EBSCOhost, https://doi.org/10.1096/fasebj.2019.33.1_supplement.662.24.

APA

Jingqiu Cheng, Fuping Zhang, Ruiwen Mao, Chengshi Wang, Yanrong Lu, & Younan Chen. (2019). Mesenchymal stem cells improve renal injury in diabetic rats by inhibiting CD103 + DCs maturation to decline CD8 + T cell responses. The FASEB Journal, 33. https://doi.org/10.1096/fasebj.2019.33.1_supplement.662.24

Chicago

Jingqiu Cheng, Fuping Zhang, Ruiwen Mao, Chengshi Wang, Yanrong Lu, and Younan Chen. 2019. “Mesenchymal Stem Cells Improve Renal Injury in Diabetic Rats by Inhibiting CD103 + DCs Maturation to Decline CD8 + T Cell Responses.” The FASEB Journal 33 (April). doi:10.1096/fasebj.2019.33.1_supplement.662.24.